Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.4B | $15.4B | $14.2B | $13.2B | $11.8B | $12.4B | $12.2B | $12.5B | $12.6B | $12.5B |
| Revenue growth | — | -16.7% | -7.8% | -6.7% | -10.8% | 4.9% | -1.3% | 2.3% | 1.2% | -1.2% |
| Operating income | -$860M | -$1.88B | $208M | $650M | $1.13B | $1.40B | $821M | $957M | $542M | $1.49B |
| Operating margin | -4.7% | -12.2% | 1.5% | 4.9% | 9.6% | 11.3% | 6.7% | 7.7% | 4.3% | 11.9% |
| Net income | -$1.72B | -$2.46B | -$788M | -$675M | $511M | $230M | $46.0M | -$133M | -$516M | $509M |
| Net margin | -9.3% | -16.0% | -5.6% | -5.1% | 4.3% | 1.9% | 0.4% | -1.1% | -4.1% | 4.1% |
| EPS (diluted) | -$15.54 | -$22.00 | -$6.99 | -$5.93 | $4.39 | $1.76 | $0.35 | -$1.02 | -$3.90 | $3.77 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.14B | $773M | $274M | $385M | $2.18B | -$131M | $300M | $210M | $480M | $543M |
| Capital expenditures | $744M | $564M | $527M | $438M | $440M | $469M | $415M | $467M | $360M | $335M |
| Free cash flow | $393M | $209M | -$253M | -$53.0M | $1.74B | -$600M | -$115M | -$257M | $120M | $208M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $238M | $563M | $196M | $216M | $1.68B | $507M | $118M | $38.0M | $37.0M | $260M |
| Total assets | $21.9B | $17.4B | $15.9B | $15.6B | $16.0B | $15.2B | $14.7B | $14.5B | $14.1B | $13.2B |
| Total liabilities | $19.7B | $17.6B | $16.8B | $17.2B | $17.1B | $16.0B | $15.4B | $15.3B | $15.4B | $14.0B |
| Long-term debt | $15.2B | $13.9B | $13.4B | $13.4B | $12.1B | $12.1B | $11.6B | $11.5B | $11.4B | $10.4B |
| Shareholders' equity | $1.61B | -$767M | -$1.53B | -$2.22B | -$1.63B | -$1.37B | -$1.37B | -$1.39B | -$1.91B | -$1.39B |
| Retained earnings | -$299M | -$2.76B | -$3.54B | -$4.22B | -$3.71B | -$3.48B | -$3.43B | -$3.56B | -$4.08B | -$3.57B |
| Shares (wtd avg diluted) | 111M | 112M | 113M | 114M | 117M | 131M | 130M | 130M | 132M | 135M |
Every figure is extracted from COMMUNITY HEALTH SYSTEMS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.